September 15, 2025

The Hidden Hazard: Fall-Risk Drugs

US fall-related deaths in older adults are rising, with prescription drugs a key contributor and safer alternatives urged.

KFF Health News

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 11, 2025

"Magic Mushroom" Edibles Lack Psilocybin

Analysis of retail products reveals widespread adulteration with synthetic compounds, posing unknown health risks.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

August 19, 2025

High-Dose Buprenorphine and Outcomes in Fentanyl Use

Studies linked higher buprenorphine doses to longer retention, not fewer withdrawal cases.

Conexiant

August 19, 2025

‘Enough Is Enough’—But When?

How Bogalusa, Louisiana became a lens on the US gun violence epidemic—where race, poverty, policy, and profit converge and communities bear the cost.

KFF Health News

August 19, 2025

ADHD Medication Use Shows Different Outcome Rates

Using national registry data, researchers observe that ADHD drug treatment is linked to lower rates of suicidal behaviours, substance misuse, transport accidents, and criminality in routine clinical settings over two years.

Conexiant

August 18, 2025

Health Groups Respond to 'National Scandal'

With elder homelessness rising, PACE programs funded by Medicaid and Medicare secure housing and health care for low-income seniors, seen in Rhode Island.

KFF Health News